These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27090386)

  • 1. Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.
    Duan L; Hu X; Jin Y; Liu R; You Q
    BMC Cancer; 2016 Apr; 16():276. PubMed ID: 27090386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
    Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis.
    Wang H; Xie F; Hu Z; Chen L
    Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
    Wang T; Li W; Li W; Liu L; Zhang H
    J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
    Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
    World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased osteopontin protein expression may be correlated with poor prognosis in non-small-cell lung cancer: A meta analysis.
    Shi SM; Su ZB; Zhao JJ; Yu DJ; Tu JW; Zhu JQ; Zhao JP; Sheng L; Wang SB; Sheng YJ; Chen HJ; Tian JH; Zhang Y; Wang J
    J Cancer Res Ther; 2016; 12(1):277-82. PubMed ID: 27072251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
    Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
    Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
    Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
    Gao Q; Yang S; Kang MQ
    Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
    Zhang J; Yu XL; Zheng GF; Zhao F
    Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
    Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features].
    Wang L; Li X; Li Y; Xue YW
    Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
    Pu Z; Wang Q; Xie H; Wang G; Hao H
    Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
    Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
    Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
    Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining.
    Li XJ; Pang JS; Li YM; Ahmed FA; He RQ; Ma J; Ma FC; Chen G
    Pathol Res Pract; 2018 Mar; 214(3):385-401. PubMed ID: 29499854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
    Li D; Cao Y; Luo CW; Zhang LP; Zou YB
    Recent Pat Anticancer Drug Discov; 2024; 19(5):599-609. PubMed ID: 37818578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.